Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Crawford

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Archives of Public Health = Archives Belges De Sante Publique|October 18, 2024
ARCHWAy: an innovative educational program advancing the public health workforceBeth Ann Swan, Quyen Phan, Kevin Crawford, et al.
Vaccine|November 16, 2004
Cationic microparticles are a potent delivery system for a HCV DNA vaccineDerek T O'Hagan, Manmohan Singh, Christine Dong, et al.
Brachytherapy|October 24, 2009
An intraoperative real-time sleeved seed technique for permanent prostate brachytherapyNavesh K Sharma, Randi J Cohen, Thomas N Eade, et al.
Vaccine|October 9, 2007
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodiesZania Stamataki, Stephen Coates, Matthew J Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancerAndre Konski, Tianyu Li, Michael Christensen, et al.
Journal of Virology|March 16, 2018
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus VaccineJohn L M Law, Michael Logan, Jason Wong, et al.
Journal of Virology|November 1, 2016
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgGMichael Logan, John Law, Jason Alexander Ji-Xhin Wong, et al.
Journal of Virology|May 30, 2008
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5Yinling Lin, Taewoo Kwon, John Polo, et al.
Vaccine|September 5, 2021
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1John Lok Man Law, Michael Logan, Michael A Joyce, et al.
Journal of Hepatology|July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 aloneJuthika Kundu, Hoa T Le, Michael Logan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Public Health = Archives Belges De Sante Publique|October 18, 2024
ARCHWAy: an innovative educational program advancing the public health workforceBeth Ann Swan, Quyen Phan, Kevin Crawford, et al.
Vaccine|November 16, 2004
Cationic microparticles are a potent delivery system for a HCV DNA vaccineDerek T O'Hagan, Manmohan Singh, Christine Dong, et al.
Brachytherapy|October 24, 2009
An intraoperative real-time sleeved seed technique for permanent prostate brachytherapyNavesh K Sharma, Randi J Cohen, Thomas N Eade, et al.
Vaccine|October 9, 2007
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodiesZania Stamataki, Stephen Coates, Matthew J Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancerAndre Konski, Tianyu Li, Michael Christensen, et al.
Journal of Virology|March 16, 2018
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus VaccineJohn L M Law, Michael Logan, Jason Wong, et al.
Journal of Virology|November 1, 2016
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgGMichael Logan, John Law, Jason Alexander Ji-Xhin Wong, et al.
Journal of Virology|May 30, 2008
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5Yinling Lin, Taewoo Kwon, John Polo, et al.
Vaccine|September 5, 2021
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1John Lok Man Law, Michael Logan, Michael A Joyce, et al.
Journal of Hepatology|July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 aloneJuthika Kundu, Hoa T Le, Michael Logan, et al.
Pageof 2